Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Platelets|September 17, 2011
A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrelFabian Chen, Victor Maridakis, Edward A O'neill, et al.
Il Giornale Di Chirurgia|June 20, 2012
Severity in biliary peritonitisL Izzo, R Gabriele, M Conte, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 9, 2008
Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factorA Mancino, M G Mancino, S S Glaser, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2017
Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone MassTony M Keaveny, Daria B Crittenden, Michael A Bolognese, et al.
JACC. Cardiovascular Imaging|January 14, 2012
Correlation between arterial FDG uptake and biomarkers in peripheral artery diseaseKelly S Myers, James H F Rudd, Eric P Hailman, et al.
The New England Journal of Medicine|February 17, 2005
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trialRobert S Bresalier, Robert S Sandler, Hui Quan, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 28, 2011
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tabletM R McClung, P D Miller, J P Brown, et al.
Bone|July 23, 2013
Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumabHarry K Genant, Cesar Libanati, Klaus Engelke, et al.
Annals of Internal Medicine|November 1, 1987
Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter studyR J Havel, D B Hunninghake, D R Illingworth, et al.
BMC Musculoskeletal Disorders|April 29, 2017
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension studyJonathan D Adachi, Henry G Bone, Nadia S Daizadeh, et al.
Pageof 17